drug
as of 2026-07-01Nicotine replacement therapy
nicotine replacement therapy
MeSH D000095488
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Duke University
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
2
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
NCT02420015Phase 4Completed
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
NCT00307203Phase 4Completed
KOLs & investigators
2
A. Eden Evins, MD, MPHKOL score 5
Jean M. Addington, Ph.D.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
A. Eden Evins, MD, MPH
personKOL score 5
Jean M. Addington, Ph.D.
personKOL score 5